Dr. Julian Watts earned his B.Sc. and Ph.D. in the United Kingdom, before moving to the University of British Columbia, Vancouver, to do his post-doctoral studies with Ruedi Aebersold. Dr. Watts next spent several years at the Department of Molecular Biotechnology at the University of Washington in Seattle, before joining Leroy Hood’s Institute for Systems Biology (ISB), also in Seattle, as a Senior Research Scientist, in September 2000. He is currently part of a substantial proteomics program at the ISB, headed, again, by Ruedi Aebersold. A major focus of this research is the development and implementation of both information and proteomic technologies for the identification of blood-borne markers for early detection of human disease, specifically targeting glycosylated cell surface and tissue derived, as well as secreted, proteins. A major effort at ISB for the application of this technology is currently aimed at early detection of breast cancer, though other disease-related projects are also ongoing, for detection of prostate and bladder cancer, as well as diabetes.